Month: October 2016

Local company, Bedfont® Scientific, urges people to quit smoking with the Smokerlyzer® after latest figures from Action on Smoking and Health (ASH) find smoking still causes the majority of lung cancer deaths in the UK.

Lung Cancer Awareness month approaches again in November 2016, in the hope to make people aware of the facts and figures that can save people’s lives. Bedfont® Scientific, based in Harrietsham, Kent, manufacturer of the Smokerlyzer®, a breath carbon monoxide (CO) monitor used to help people quit smoking, is encouraging people to quit the habit which contributes to 86% of lung cancer deaths in men and 72% in women, according to latest ASH statistics.

A staggering 81% of patients diagnosed with advanced lung cancer die within a year and smoking is the single biggest preventable risk factor of lung cancer.

A leading manufacturer of exhaled breath and gas monitoring instruments, who in 2016 are celebrating two important anniversaries – 40 years in business and 30 years of one of their most successful exports – the Smokerlyzer®, Bedfont® Scientific are revered as pioneers in the medical gas analysis market.

Jason Smith, Managing Director at Bedfont® Scientific, comments,

“The Smokerlyzer® uses breath analysis to detect the harmful amount of carbon monoxide (CO) in your lungs, and therefore your blood, that is inhaled from smoking. Smoking builds high levels of CO in the blood, which can lead to heart disease, circulation problems and high blood pressure. For smoking cessation clinics, it is a way to establish a smoker’s status whilst acting as a motivational visual aid to encourage them to quit and to measure their progress whilst doing so, helping to prevent cancer and other smoking related diseases.”

At Bedfont’s 40th year in business celebrations, Jason Smith was announced as Managing Director, succeeding his father, Trevor, who becomes Chairman.

Bedfont Scientific Ltd, based in Harrietsham, gathered together its customers, distributors and partners in celebration of 40 years trading, where Trevor Smith announced that Bedfont was becoming a 2nd generation family company by appointing his son, Jason Smith, as the new Managing Director, with Trevor moving on to the position of Chairman.

Trevor Smith joined Bedfont as the Marketing Director in 1985. It is from there that Trevor grew and became managing director of Bedfont Scientific, shaping it to be the pioneer in medical breath analysis that it is today.

Trevor Smith, Chairman of Bedfont, says, “It is with great pride and pleasure that I hand the reins over to my son Jason. I couldn’t be more proud of the man that Jason has become and I have absolutely no doubt that he has the brightest future for Bedfont at the heart of his strategies.”

Jason Smith, new Managing Director of Bedfont, adds, “I’d like to thank Trevor for trusting me with the company he built, he’s been the best business mentor and friend I could have hoped for. My aim for Bedfont is that our family values are shown through our dedication to our customers and our core business of breath analysis; we all share the same goal of providing the best service and products to improve healthcare. This goes not only for our employees, but also our distributors and suppliers; it’s about the Bedfont family, not just the Smith family, and I’m proud to work with them all.”